Literature DB >> 18279993

Disease-specific health-related quality of life instruments among adults diabetic: A systematic review.

Youness El Achhab1, Chakib Nejjari, Mohamed Chikri, Badiaa Lyoussi.   

Abstract

This paper provides a systematic review on health-related quality of life (HRQoL) measures in diabetic patients. For each included study, a description of the measure and its psychometric findings is provided. To evaluate these measures, a databases search (Medline, Scopus and Proqolid) was undertaken to identify relevant publications. Instruments were assessed according to predefined inclusion and exclusion criteria. Sixteen instruments met the inclusion criteria among 1049 references produced: appraisal of diabetes scale (ADS), audit of diabetes-dependent quality of life (ADDQoL), diabetes-39 (D-39), diabetes care profile (DCP), diabetes distress scale (DDS), diabetes health profile (DHP-1, DHP-18), diabetes impact measurement scales (DIMS), diabetes quality of life measure (DQOL), diabetes quality of life clinical trial questionnaire-revised (DQLCTQ-R), diabetes-specific quality of life scale (DSQOLS), elderly diabetes burden scale (EDBS), insulin delivery system rating questionnaire (IDSRQ), quality of life with diabetes questionnaire (LQD), problem areas in diabetes scale (PAID), questionnaire on stress in diabetic patients-revised (QSD-R) and well-being enquiry for diabetics (WED). All those instruments have been developed in northern countries. The shortest instrument (ADS) has seven items and the longest (IDSRQ) has 67 items. ADDQoL was widely translated followed by DHP and PAID. Only authors of ADS and DIMS have not involved patients in the construction of instruments. The authors of instruments: ADS, ADDQoL, DHP, D-39, and PAID reported the item-total correlation which is ranged from 0.28 to 0.84. The ADS, DQOL, EDBS, IDSRQ, LQD, PAID, QSD-R, and WED have been assessed for test-retest reliability which varies between 0.27 and 0.99. The DQLCTQ-R, DQOL and IDSRQ were not subjected to factor analysis. Responsiveness was assessed in PAID with effect sizes and ranged from 0.32 to 0.65 for interventions. Four domains were responsive to clinical change in metabolic control in DQLCTQ-R. The other instruments were not been formally assessed for responsiveness. This review found evidence that the instruments: ADDQoL, D-39, DDS, DHP1/18, DSQOLS, EDBS and QSD-R had adequate psychometric properties. For future research, responsiveness should be a priority and further study is also required to examine the effect of ethnicity and to determine the validity of these scales in developing countries.

Entities:  

Mesh:

Year:  2008        PMID: 18279993     DOI: 10.1016/j.diabres.2007.12.020

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  61 in total

1.  Implementation of an integrated primary care cardiometabolic risk prevention and management network in Montréal: does greater coordination of care with primary care physicians have an impact on health outcomes?

Authors:  Sylvie Provost; Raynald Pineault; Dominique Grimard; José Pérez; Michel Fournier; Yves Lévesque; Johanne Desforges; Pierre Tousignant; Roxane Borgès Da Silva
Journal:  Health Promot Chronic Dis Prev Can       Date:  2017-04       Impact factor: 3.240

2.  Outcome tools for diabetes-specific quality of life: Study performed in a private family practice clinic.

Authors:  Rajesh Nair; Paul Kachan
Journal:  Can Fam Physician       Date:  2017-06       Impact factor: 3.275

3.  Medication adherence on quality of life among adults with type 2 diabetes mellitus: an exploratory analysis on the EDDMQoL study.

Authors:  Boon-How Chew
Journal:  Qual Life Res       Date:  2015-05-23       Impact factor: 4.147

4.  Assessing the impact of non-severe hypoglycemic events and treatment in adults: development of the Treatment-Related Impact Measure-Non-severe Hypoglycemic Events (TRIM-HYPO).

Authors:  Meryl Brod; Lise Højbjerre; Donald M Bushnell; Charlotte Thim Hansen
Journal:  Qual Life Res       Date:  2015-06-21       Impact factor: 4.147

Review 5.  Advancing Measurement of Diabetes at the Population Level.

Authors:  Mohammed K Ali; Karen R Siegel; Michael Laxy; Edward W Gregg
Journal:  Curr Diab Rep       Date:  2018-09-19       Impact factor: 4.810

6.  Quality of life assessment in patients with HNF1A-MODY and GCK-MODY.

Authors:  Magdalena Szopa; Bartlomiej Matejko; Damian Ucieklak; Agata Uchman; Jerzy Hohendorff; Sandra Mrozińska; Wojciech Głodzik; Barbara Zapała; Teresa Płatek; Iwona Solecka; Cyrus M Sani; Maciej T Małecki
Journal:  Endocrine       Date:  2018-11-12       Impact factor: 3.633

7.  Short-form measures of diabetes-related emotional distress: the Problem Areas in Diabetes Scale (PAID)-5 and PAID-1.

Authors:  B E McGuire; T G Morrison; N Hermanns; S Skovlund; E Eldrup; J Gagliardino; A Kokoszka; D Matthews; M Pibernik-Okanović; J Rodríguez-Saldaña; M de Wit; F J Snoek
Journal:  Diabetologia       Date:  2009-10-20       Impact factor: 10.122

Review 8.  Alzheimer's disease drug development: old problems require new priorities.

Authors:  Robert E Becker; Nigel H Greig
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-12       Impact factor: 4.388

9.  The differential associations of depression and diabetes distress with quality of life domains in type 2 diabetes.

Authors:  Matthew M Carper; Lara Traeger; Jeffrey S Gonzalez; Deborah J Wexler; Christina Psaros; Steven A Safren
Journal:  J Behav Med       Date:  2013-03-21

10.  Fatness and fitness: how do they influence health-related quality of life in type 2 diabetes mellitus?

Authors:  Wendy L Bennett; Pamela Ouyang; Albert W Wu; Bethany B Barone; Kerry J Stewart
Journal:  Health Qual Life Outcomes       Date:  2008-12-04       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.